Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases
V Del Pozo, I Bobolea, MJ Rial… - Frontiers in …, 2024 - frontiersin.org
Eosinophil-related diseases represent a group of pathologic conditions with highly
heterogeneous clinical presentation and symptoms ranging from mild to critical. Both …
heterogeneous clinical presentation and symptoms ranging from mild to critical. Both …
Treatment of giant cell arteritis (GCA)
A Régent, L Mouthon - Journal of Clinical Medicine, 2022 - mdpi.com
Giant cell arteritis (GCA) is the most frequent primary large-vessel vasculitis in individuals
older than 50. Glucocorticoids (GCs) are considered the cornerstone of treatment. GC …
older than 50. Glucocorticoids (GCs) are considered the cornerstone of treatment. GC …
An Initiative to Improve Timely Glucocorticoid Tapering in Vasculitis
A Mendel, D Ennis, S Lake, S Carette… - JCR: Journal of …, 2021 - journals.lww.com
Methods For each patient referred for anti–neutrophil cytoplasm antibody–associated
vasculitis (AAV) or large vessel vasculitis (LVV), recommendation-based GC tapering …
vasculitis (AAV) or large vessel vasculitis (LVV), recommendation-based GC tapering …